共 50 条
- [1] EARLY AND CONSISTENT IMPROVEMENTS IN QUALITY OF LIFE AND URINARY SYMPTOMS WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A RANDOMIZED, PLACEBO-CONTROLLED TRIALNEUROUROLOGY AND URODYNAMICS, 2018, 37 : S578 - S579McCammon, KurtGousse, AngeloGruenenfelder, JenniferHale, DouglassOrejudos, AmeliaAboushwareb, TamerKohan, Alfred
- [2] EARLY AND CONSISTENT IMPROVEMENTS IN URINARY SYMPTOMS AND QUALITY OF LIFE WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIALTOXICON, 2018, 156 : S79 - S79McCammon, KurtGousse, AngeloGruenenfelder, JenniferHale, DouglassOrejudos, AmeliaAboushwareb, TamerPatel, AnandKohan, Alfred
- [3] Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical TrialFEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (07): : 450 - 456McCammon, KurtGousse, AngeloKohan, AlfredGlazier, DavidGruenenfelder, JenniferBai, ZhanyingPatel, AnandHale, Douglass
- [4] EARLY AND CONSISTENT IMPROVEMENTS IN URINARY SYMPTOMS AND QUALITY OF LIFE IN IDIOPATHIC OVERACTIVE BLADDER PATIENTS FOLLOWING REPEAT TREATMENT WITH ONABOTULINUMTOXINA: RESULTS OF A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIALNEUROUROLOGY AND URODYNAMICS, 2018, 37 : S395 - S396McCammon, K.Gousse, A.Gruenenfelder, J.Hale, D.Orejudos, A.Patel, A.Kahan, A.
- [5] EARLY ONSET AND CONSISTENT RESPONSE OF ONABOTULINUMTOXINA TREATMENT WITH SIGNIFICANT RESOLUTION OF URINARY SYMPTOMS IN FEMALE OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIALINTERNATIONAL UROGYNECOLOGY JOURNAL, 2017, 28 : S19 - S20Mccammon, K.Gruenenfelder, J.Lucente, V. R.Orejudos, A.Aboushwareb, T.Hale, D. S.
- [6] OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled TrialJOURNAL OF UROLOGY, 2013, 189 (06): : 2186 - 2193Nitti, Victor W.Dmochowski, RogerHerschorn, SenderSand, PeterThompson, CatherineNardo, ChristopherYan, XiaohongHaag-Molkenteller, Cornelia
- [7] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled TrialEUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256Chapple, ChristopherSievert, Karl-DietrichMacDiarmid, ScottKhullar, VikRadziszewski, PiotrNardo, ChristopherThompson, CatherineZhou, JihaoHaag-Molkenteller, Cornelia
- [8] ONABOTULINUMTOXINA PROVIDES EARLY AND CONSISTENT IMPROVEMENTS IN OVERACTIVE BLADDER SYMPTOMS AND QUALITY OF LIFE OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDERJOURNAL OF UROLOGY, 2017, 197 (04): : E510 - E510McCammon, KurtKohan, AlfredKaminetsky, JedGousse, AngeloGruenenfelder, JenniferOrejudos, AmeliaAboushwareb, TamerMacDiarmid, Scott
- [9] LONG-TERM IMPROVEMENTS IN QUALITY OF LIFE FOLLOWING ONABOTULINUMTOXINA TREATMENT IN FEMALE PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCEINTERNATIONAL UROGYNECOLOGY JOURNAL, 2014, 25 : S61 - S62Sand, P. K.Khullar, V.Joshi, M.Zheng, Y.Nitti, V.
- [10] ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCEINTERNATIONAL UROGYNECOLOGY JOURNAL, 2012, 23 : S191 - S192Sand, P. K.Khalaf, K. M.Yan, X.Globe, D.